BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17078964)

  • 1. Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.
    Zhang MY; Choudhry V; Sidorov IA; Tenev V; Vu BK; Choudhary A; Lu H; Stiegler GM; Katinger HW; Jiang S; Broder CC; Dimitrov DS
    J Immunol Methods; 2006 Dec; 317(1-2):21-30. PubMed ID: 17078964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive antigen panning for selection of HIV-1 neutralizing human monoclonal antibodies specific for gp41.
    Zhang MY; Dimitrov DS
    Methods Mol Biol; 2009; 525():175-86, xv. PubMed ID: 19252830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.
    Choudhry V; Zhang MY; Sidorov IA; Louis JM; Harris I; Dimitrov AS; Bouma P; Cham F; Choudhary A; Rybak SM; Fouts T; Montefiori DC; Broder CC; Quinnan GV; Dimitrov DS
    Virology; 2007 Jun; 363(1):79-90. PubMed ID: 17306322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency.
    Zhang MY; Dimitrov DS
    Curr Pharm Des; 2007; 13(2):203-12. PubMed ID: 17269928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
    Zhang MY; Xiao X; Sidorov IA; Choudhry V; Cham F; Zhang PF; Bouma P; Zwick M; Choudhary A; Montefiori DC; Broder CC; Burton DR; Quinnan GV; Dimitrov DS
    J Virol; 2004 Sep; 78(17):9233-42. PubMed ID: 15308718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
    Zhang MY; Vu BK; Choudhary A; Lu H; Humbert M; Ong H; Alam M; Ruprecht RM; Quinnan G; Jiang S; Montefiori DC; Mascola JR; Broder CC; Haynes BF; Dimitrov DS
    J Virol; 2008 Jul; 82(14):6869-79. PubMed ID: 18480433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.
    Stiegler G; Kunert R; Purtscher M; Wolbank S; Voglauer R; Steindl F; Katinger H
    AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1757-65. PubMed ID: 11788027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
    Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41.
    Louis JM; Bewley CA; Gustchina E; Aniana A; Clore GM
    J Mol Biol; 2005 Nov; 353(5):945-51. PubMed ID: 16216270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.
    Binley JM; Wrin T; Korber B; Zwick MB; Wang M; Chappey C; Stiegler G; Kunert R; Zolla-Pazner S; Katinger H; Petropoulos CJ; Burton DR
    J Virol; 2004 Dec; 78(23):13232-52. PubMed ID: 15542675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.
    Gustchina E; Louis JM; Frisch C; Ylera F; Lechner A; Bewley CA; Clore GM
    Virology; 2009 Oct; 393(1):112-9. PubMed ID: 19695655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding.
    Binley JM; Ditzel HJ; Barbas CF; Sullivan N; Sodroski J; Parren PW; Burton DR
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):911-24. PubMed ID: 8798976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
    J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein.
    Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential antigen panning for selection of broadly cross-reactive HIV-1-neutralizing human monoclonal antibodies.
    Zhang MY; Dimitrov DS
    Methods Mol Biol; 2009; 562():143-54. PubMed ID: 19554293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
    Blish CA; Nguyen MA; Overbaugh J
    PLoS Med; 2008 Jan; 5(1):e9. PubMed ID: 18177204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains.
    Gustchina E; Louis JM; Lam SN; Bewley CA; Clore GM
    J Virol; 2007 Dec; 81(23):12946-53. PubMed ID: 17898046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-neutralizing monoclonal antibody 4E10 recognizes N-terminal sequences on the native antigen.
    Hager-Braun C; Katinger H; Tomer KB
    J Immunol; 2006 Jun; 176(12):7471-81. PubMed ID: 16751393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.